Corpus ID: 120106673

A Valuable Insight Impact of Pharmacist in Pharmacogenomics

@inproceedings{Hasmi2018AVI,
  title={A Valuable Insight Impact of Pharmacist in Pharmacogenomics},
  author={Sana Hasmi and Gamal Osman Elhassan and Shamshir Khan and Mohammad Afzal Rashid.},
  year={2018}
}
DOI: 10.21276/sajp.2017.6.12.8 Abstract: Pharmacogenomics is the study of genetic variations that influence individual response to drugs. Knowing whether a patient carries any of these genetic variations can help prescribers individualize drug therapy, decrease the chance for adverse drug events and increase the effectiveness of drugs. Pharmacist must be aware with the new technologies so as to take advantage of these new opportunities for the benefit of patients. Pharmacist must further… Expand

References

SHOWING 1-10 OF 44 REFERENCES
Integrating pharmacogenomics into pharmacy practice via medication therapy management
TLDR
The pharmacy profession must define a process for the application of pharmacogenomic data into pharmacy clinical practice that is aligned with MTM service delivery, develop a viable business model for these practices, and encourage and direct the development of an effective infrastructure for this process. Expand
Translation of pharmacogenomics and pharmacogenetics: a regulatory perspective
TLDR
This challenge of integration of pharmacogenomics and pharmacogenetics into routine clinical practice remains a major multidisciplinary challenge, and even for well-established biomarkers there has been little progress. Expand
Priorities and standards in pharmacogenetic research
TLDR
As the attention of researchers begins to shift toward more systematic pharmacogenetic investigations, it is suggested some priorities and standards for pharmacogenetics research. Expand
Recommended Basic Science Foundation Necessary to Prepare Pharmacists to Manage Personalized Pharmacotherapy
TLDR
The curricular outcomes described are the minimum expectation for future pharmacists to provide optimal patient care in the era of personalized medicine, and are a useful resource for academicians involved in curricular content development for pharmacy students. Expand
RESEARCH ARTICLES Pharmacogenetics and Pharmacogenomics Instruction in Colleges and Schools of Pharmacy in the United States
TLDR
Although the majority of surveyed schools provide some instruction in pharmacogenetics/pharmacogenomics and plan to increase it in the coming years, many presently do not provide the depth recommended by AACP’s Academic Cabinet. Expand
Pharmacogenetics of the antiepileptic drugs phenytoin and lamotrigine
TLDR
An overview of the current knowledge on the pharmacogenetics of two commonly prescribed antiepileptic drugs with similar mechanisms of action; phenytoin (PHT) and lamotrigine (LTG) is provided. Expand
Cancer pharmacogenomics: powerful tools in cancer chemotherapy and drug development.
TLDR
The current and future applications of pharmacogenomics in clinical cancer therapy and cancer drug development are discussed. Expand
Pharmaceutical education in the wake of genomic technologies for drug development and personalized medicine.
  • I. Vizirianakis
  • Medicine
  • European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
  • 2002
The development of safe and effective new therapeutics is a long, difficult, and expensive process. Over the last 20-30 years, recombinant DNA (rDNA) technology has provided a multiple of newExpand
Emergence and Evolution of Pharmacogenetics and Pharmacogenomics in Clinical Pharmacy over the Past 40 Years
TLDR
In 2007, articles reflecting on the history of clinical pharmacy through the eyes of practitioners, including those pioneering clinical pharmacy, as well as those who have more recently entered the profession and a well-established specialty are being published. Expand
Assessment of clinical pharmacist management of lipid-lowering therapy in a primary care setting.
TLDR
Interdisciplinary medical teams that includeclinical pharmacists who are actively prescribing and adjusting lipid drug therapy may achieve greater reductions in LDL for patients who have been assessed with multiple risk factors compared to patients managed without clinical pharmacists. Expand
...
1
2
3
4
5
...